Shenzhen Chipscreen Biosciences Co año OPV
¿Qué es el año OPV de Shenzhen Chipscreen Biosciences Co?
El año OPV de Shenzhen Chipscreen Biosciences Co., Ltd. es 2019
¿Cuál es la definición de año OPV?
La oferta pública inicial es un tipo de oferta pública en la cual las acciones de una compañía generalmente se venden a inversionistas institucionales que, a su vez, venden al público en general, en una bolsa de valores, por primera vez.
Through IPO a privately held company transforms into a public company. Initial public offerings are mostly used by companies to raise the expansion of capital, possibly to monetize the investments of early private investors, and to become publicly traded enterprises. A company selling shares is never required to repay the capital to its public investors. After the IPO, when shares trade freely in the open market, money passes between public investors.
Although IPO offers many advantages, there are also significant disadvantages, chief among these are the costs associated with the process and the requirement to disclose certain information that could prove helpful to competitors.
The IPO process is colloquially known as going public. Details of the proposed offering are disclosed to potential purchasers in the form of a lengthy document known as a prospectus. Most companies undertake an IPO with the assistance of an investment banking firm acting in the capacity of an underwriter. Underwriters provide several services, including help with correctly assessing the value of shares.
año OPV de compañías en Sector Health Care en SSE en comparadas con Shenzhen Chipscreen Biosciences Co
¿Qué hace Shenzhen Chipscreen Biosciences Co?
Shenzhen Chipscreen Biosciences Co., Ltd. engages in the research, development, and sale of original small molecule drugs. The company develops precursor compounds and original new drug product lines that are in various research phase of the specific global intellectual property protection in three areas, such as cancer, metabolic diseases, and autoimmune diseases. Shenzhen Chipscreen Biosciences Co., Ltd. was founded in 2001 and is based in Shenzhen, China.
Empresas con año opv similar a Shenzhen Chipscreen Biosciences Co
- W.I.S.E. - Nasdaq Overseas China New Economy Companies Top 50 Index Tracker Fund tiene año OPV de 2018
- iShares II Public - iShares $ TIPS UCITS ETF tiene año OPV de 2018
- Ladenburg Thalmann Services 7.00% SN NT 28 tiene año OPV de 2018
- CSOP Hong Kong Dollar Money Market ETF tiene año OPV de 2018
- Tempus Resources tiene año OPV de 2018
- China Asset Management company Bloomberg Barclays China Treasury Policy Bank bond index ETF tiene año OPV de 2018
- Shenzhen Chipscreen Biosciences Co tiene año OPV de 2019
- Del Taco Restaurants tiene año OPV de 2020
- Centene tiene año OPV de 2020
- Novo Nordisk A/S tiene año OPV de 2020
- Pensana Rare Earths Plc tiene año OPV de 2020
- Auralite Investments tiene año OPV de 2020
- Tilray tiene año OPV de 2020